Primer: Oxford Nanopore Technologies (ONT LN) - Aug 2026
Disruptive Technology Platform: Oxford Nanopore's unique nanopore sequencing technology offers real-time data, scalability, and the ability to...
111 Views
Hardman & Co Healthcare Index: 2024 – Tough year for Life Sciences
The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments...
514 Views
Axbio (安序源) Pre-IPO: First Take of the Deal
China's Axbio plans to raise $100 million in Hong Kong listing with CICC and SPDB as joint sponsors, but doubts remain on deal prospects after...
649 Views
Coca-Cola Europacific Partners (CCEP LN): Halfway In F100
CCEP LN recently transferred to the index's eligible FCA listing category and will be added to F100 in March 2025 if it passes the liquidity test.
435 Views
Hardman & Co Monthly: January 2025
Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to...
647 Views